Agriculture And Food Tenders

Oh-Biologika-2023-13 - Insulin Isophane (Human) (Dosage Form: Cylinder Ampoules)

Oh-Biologika-2023-12 - Insulin, Normal (Human) (Dosage Form: Cylinder Ampoules)

Saso - Security Assessment and System Optimisation

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Ingredient Bimatoprost (Atc Code According to Who: S01ee03)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Abs. 8 Sgb V for the Active Ingredient Dapagliflozin

Contract for the Distribution Partnership for the Phoenix Product Group

Completion of Non-exclusive Drug Discounts According to Section 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Bimatoprost (atc Code According to Who: S01e03)

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Dynamic Procurement System for Food and Beverage Procurement